Showing results (461-470 of 495) with videos related to
Sort By:
Pageof 50
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancerC Aghajanian, D Fennelly, F Shapiro, et al.Gynecologic Oncology|October 7, 2006
Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancerCatherine S M Diefenbach, Zharna Shah, Alexia Iasonos, et al.Gynecologic Oncology|October 16, 2012
A prospective study of quality of life in patients undergoing pelvic exenteration: interim resultsYoussef A Rezk, Karen E Hurley, Jeanne Carter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systemsOliver Zivanovic, Mario M Leitao, Alexia Iasonos, et al.Cancer|December 6, 2011
Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancerDavid M Hyman, Qin Zhou, Alexia Iasonos, et al.Plos One|May 4, 2010
Genetic analysis of the early natural history of epithelial ovarian carcinomaBhavana Pothuri, Mario M Leitao, Douglas A Levine, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 2013
Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)Stephanie L Wethington, Kay J Park, Robert A Soslow, et al.Gynecologic Oncology|July 9, 2010
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomasDennis S Chi, Oliver Zivanovic, Kimberly L Levinson, et al.The New England Journal of Medicine|May 25, 2002
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutationNoah D Kauff, Jaya M Satagopan, Mark E Robson, et al.American Journal of Obstetrics and Gynecology|June 26, 2010
Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma riskMario M Leitao, Guangming Han, Lisa X Lee, et al.Pageof 50